• The abstract word limit is max. 250 words per abstract excl. title, authors and affiliations. The EWMA Secretariat reserves the right to edit abstracts that exceed the word limit
• The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end
• No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online
• The abstract must include the following:
Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them
• All abbreviations must be defined in first use. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
• Use of brand names: For all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. EWMA reserves the right to replace any brand name with a generic name without further notice
• Abstracts will not be accepted if previously presented at a EWMA conference unless there is a substantial increase in data.